ClinicalTrials.gg
RecruitingNCT05557331Updated Aug 19, 2025

Effectiveness of a Mobile App in Reducing Therapeutic TAT in an Emergency Department

An interventional study of PIMPmyHospital (mobile app) in Pediatric Emergency Medicine and Therapeutic Turnaround Time, sponsored by Pediatric Clinical Research Platform. Recruiting at 2 sites in Switzerland. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-19.

Primary conditionnone(registry's first term: Emergencies)No conditionIs this wrong?Emergencies describes something many studies share rather than a condition a study is about. The study names no condition we can place it under, so it is not compared with other studies by condition.

Sponsored by Pediatric Clinical Research Platform · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is a single center, non-equivalent comparison group, pre-post study in a tertiary pediatric emergency department in Switzerland. the study will compare the control and experimental groups on outcome measures before (12-month period) and after (6-month period) the intervention consisting of the implementation and use of the evidence-based mobile app-the ''Patients In My Pocket in my Hospital'' (PIMPmyHospital) app.

The primary outcome will be the mean elapsed time in minutes between the delivery of lab results and the emergency department caregivers accessing them before (i.e., on the institutional electronic medical records) and after the implementation of the app (i.e, directly on the app).

Read the detailed description

The study objective is to evaluate whether the use of the PIMPmyHospital app alters emergency departments (ED) physicians and nurses' temporal efficiency to learn about laboratory results more quickly while actively working in an ED. Temporal efficiency will be assessed by measuring the time between the release of the laboratory results in the clinical information system and their acknowledgement by these clinicians. Information regarding the app has been published previously (doi.org/10.3390/jpm12030428).

The investigators will conduct an 18-month, single center, non-equivalent comparison group, pre-post study. The study will compare the control and experimental groups on outcome measures before (12-month period) and after (6-month period) the intervention consisting of the use of the app. The study will take place in the pediatric ED of a tertiary referral and major trauma hospital in Switzerland, with an annual volume of 35,000 visits.

Eligible participants will be postgraduate residents pursuing a \<6-year residency in pediatrics, pediatric emergency medicine fellows, and registered nurses from the pediatric ED (aged > 18 years). Written informed consent will be obtained from each participant in the interventional group after full information disclosure prior to study participation.

Before the implementation of the app, electronic medical records (EMR)-based data from the past 12 months will be collected retrospectively. These data include the times (i.e., HH:MM:SS) that results issued by the central laboratory were available on the institutional's EMR, as well as the times at which these results were accessed by caregivers via conventional computerized workstations. (ii) After the implementation of the app, data will be collected prospectively over a 6-month period of use. This will include the times (HH:MM:SS) when the results issued by the central laboratory are made available on caregivers' mobile app and access times, as well as concurrent or preferred access times on the conventional computerized workstations should this occur. Individual acceptance of the app on the first day (a priori), at 1 week, and then on the last day of the intervention (6 months) will be evaluated through the Unified Theory of Acceptance, and Use of Technology (UTAUT). Usability of the app will be measured by the System Usability Scale (SUS).

The primary outcome will be the mean elapsed time in minutes between the delivery of the lab results and the caregiver accessing them, both before and after the implementation of the app.

02

Conditions studied

  • Pediatric Emergency Medicine
  • Therapeutic Turnaround Time

Browse trials for

Keywords

  • Information technologies
  • Mobile Applications
  • Laboratory Result Delivery
  • Therapeutic turnaround time
  • Information Storage and Retrieval
  • Hospital Communication Systems
  • Pediatric Emergency Medicine
  • Emergency Department
03

In context

Lead sponsor

Pediatric Clinical Research Platform is the lead sponsor of 14 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any postgraduate residents pursuing a \<6 years residency in pediatrics.
  • Any pediatric emergency medicine fellows.
  • To be registered nurses from the pediatric emergency department.
  • Participation agreement.

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
18 participants (estimated)

Study arms

  • No intervention
    Pre-intervention (no app)

    Participants before (12-month retrospective period) the implementation of the app in the emergency department.

  • Active comparator
    Post-intervention (PIMPmyHospital app)

    Participants that will use the mobile heath PIMPmyHospital app during the prospective 6-month period after the implementation of the app in the emergency department.

    Device: PIMPmyHospital (mobile app)

Interventions

  • DevicePIMPmyHospital (mobile app)

    After the implementation of the app, data will be collected prospectively over a 6-month period of use. This will include the times (HH:MM:SS) when the results issued by the central laboratory are made available on caregivers' mobile app and access times (as well as concurrent or preferred access times on the conventional computerized workstations should this occur).

06

What researchers measure

Primary outcomes

  1. Time to lab results review

    The mean elapsed time in minutes between the delivery of the lab results and the caregiver accessing them, both before and after the implementation of the app.

    Time frame: 1 year (retrospective) and 6 months (prospective)

Secondary outcomes

  1. Unified Theory of Acceptance, and Use of Technology (UTAUT)

    Acceptance of the app by participants on the first day (a priori) and then at 1 week and on the last day of the intervention will be evaluated through the Unified Theory of Acceptance, and Use of Technology (UTAUT) questionnaire. The UTAUT is a 8-construct, 31-item questionnaire. The items are measure along a 5-point Likert scale, which ranges from "strongly agree" (1) to "strongly disagree" (5).

    Time frame: 6 months

  2. System Usability Scale (SUS)

    Usability of the app will be measured by the System Usability Scale (SUS). The SUS comprises a 10-item questionnaire with 5 response options for each item based on their level of agreement, ranging from 1 (strongly disagree) to 5 (strongly agree). For odd-numbered statements (the positively worded items), the score contribution is equal to the scale position minus 1. For even-numbered statements (the negatively worded items), the score contribution is equal to 5 minus the scale position. Each score contribution falls within the range of 0 to 4. The participants' scores for each item are then added up together and multiplied by 2.5 to convert the original scores of 0 to 40 to 0 to 100. The higher the score, the better the usability.

    Time frame: 6 months

  3. Emergency department length of stay

    The emergency department length of stay per patient measured from the point when patients are triaged in the ED to when discharged from the ED, defined as patients leaving the ED whether admitted to the intensive care unit or ward, transferred to another hospital for admission, discharged home, or those who left without being seen.

    Time frame: 1 year (retrospective) and 6 months (prospective)

  4. Cognitive alerts

    Whether specific alerts, such as a flashing icon or sound for reported pathological values of laboratory results on the mobile app have an impact on the results. This will be measured using a questionnaire that each participant using the app will answer on a 5-point Likert scale, ranging from "strongly agree" (1) to "strongly disagree" (5).

    Time frame: 1 year (retrospective) and 6 months (prospective)

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Ehrler F, Tuor C, Rey R, Siebert JN. A Mobile App to Improve Patient Management in Emergency Departments: Caregiver Needs Analysis, Design and Early Technology Acceptance Assessment. Stud Health Technol Inform. 2021 Oct 27;285:233-238. doi: 10.3233/SHTI210605. PubMed 34734879 ↗
  • Ehrler F, Tuor C, Trompier R, Berger A, Ramusi M, Rey R, Siebert JN. Effectiveness of a Mobile App in Reducing Therapeutic Turnaround Time and Facilitating Communication between Caregivers in a Pediatric Emergency Department: A Randomized Controlled Pilot Trial. J Pers Med. 2022 Mar 9;12(3):428. doi: 10.3390/jpm12030428. PubMed 35330427 ↗
  • Ehrler F, Tuor C, Rey R, Trompier R, Berger A, Ramusi M, Courvoisier DS, Siebert JN. Effectiveness of a Mobile App (PIMPmyHospital) in Reducing Therapeutic Turnaround Times in an Emergency Department: Protocol for a Pre- and Posttest Study. JMIR Res Protoc. 2023 May 3;12:e43695. doi: 10.2196/43695. PubMed 37133909 ↗

Individual participant data

Plan to share: Yes — Individual Participant Data will be deidentified and the study investigators will house the data locally on REDCap hosted on secured servers at the Geneva University Hospitals. The datasets used or analyzed during the current trial will be available from the corresponding author upon reasonable request, recognizing that these data will only provide results for the current pre-post study and not for future trials that would follow. Only deidentified/anonymized data will be shared.

Supporting information: Study protocol

Time frame: Available from 6 month to 5 years after trial publication.

Access criteria: Data will be made available from the corresponding author upon approval of a proposal and with a signed data access agreement. Deidentified participant data will be made available to qualified external researchers whose proposed use of the data has been approved by their Institutional Review Board. Data will be made available for a specified research purpose. The request proposal must include a statistician.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2025 (actual). Primary completion is estimated for Nov 2025, 8 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2022
First posted
Sep 28, 2022
StartActual
Mar 1, 2025
Primary completionEst.
Nov 30, 2025
CompletionEst.
Dec 1, 2025
Last update
Aug 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05557331
Lead sponsor
Pediatric Clinical Research Platform
Responsible party
Johan Siebert, MD (MD, Deputy Head of the Pediatric Emergency Department, Pediatric Emergency Physician, Pediatric Clinical Research Platform) — Principal investigator
First posted
Sep 28, 2022
Start date
Mar 1, 2025
Primary completion
Nov 30, 2025 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
Aug 19, 2025

Study contacts

Johan N Siebert, MD
Contact
Johan.Siebert@hcuge.ch
+41 79 553 40 72
Frederic Ehrler, PhD
Contact
Frederic.Ehrler@hcuge.ch
Johan N Siebert, MD
study director · Geneva Children's Hospital, Geneva University Hospitals, Geneva, Switzerland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion